KARBINAL Drug Patent Profile
✉ Email this page to a colleague
When do Karbinal patents expire, and what generic alternatives are available?
Karbinal is a drug marketed by Aytu and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in KARBINAL is carbinoxamine maleate. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Karbinal
A generic version of KARBINAL was approved as carbinoxamine maleate by GENUS on March 19th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KARBINAL?
- What are the global sales for KARBINAL?
- What is Average Wholesale Price for KARBINAL?
Summary for KARBINAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for KARBINAL |
| What excipients (inactive ingredients) are in KARBINAL? | KARBINAL excipients list |
| DailyMed Link: | KARBINAL at DailyMed |
US Patents and Regulatory Information for KARBINAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aytu | KARBINAL ER | carbinoxamine maleate | SUSPENSION, EXTENDED RELEASE;ORAL | 022556-001 | Mar 28, 2013 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Aytu | KARBINAL ER | carbinoxamine maleate | SUSPENSION, EXTENDED RELEASE;ORAL | 022556-001 | Mar 28, 2013 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
